ACE2 Protein Expression During Childhood, Adolescence, and Early Adulthood. (July 2022)

• Record Type: Journal Article
• Authors: Schurink, Bernadette; Roos, Eva; Vos, Wim; Breur, Marjolein; van der Valk, Paul; Bugiani, Marianna
• Is Part Of: Pediatric and developmental pathology. Volume 25:Number 4(2022)
• Page Start: 404
• Page End: 408
• Publication Date: 2022-07
• Subjects: ACE2 -- children -- SARS-CoV-2 -- immunohistochemistry; Pediatric pathology -- Periodicals; Children -- Diseases -- Periodicals; Diagnosis, Laboratory -- Periodicals; Abnormalities, Human -- Periodicals; Child development -- Periodicals; Pediatrics -- Periodicals; 616.07
• DOI: 10.1177/10935266221075312
• Languages: English
• ISSNs: 1093-5266

Abstract

Purpose and context . Angiotensin-converting enzyme 2 is the entry receptor for SARS-CoV and SARS-CoV-2. Variations in ACE2 expression might explain age-related symptomatology of COVID-19, that is, more gastro-intestinal symptoms and less pulmonary complaints. This study qualitatively investigated ACE2 protein expression in various organs from the fetal to the young adolescent stage.Method . Autopsy samples from lung, heart, liver, stomach, small intestine, pancreas, kidney, adrenals, and brain (when available) were obtained from twenty subjects aged 24 weeks gestational age through 28 years. Formalin-fixed paraffin-embedded 4-um-thick tissue sections were stained against ACE2.Key results . We showed that the extent of ACE2 expression is age-related. With age, expression increases in lungs and decreases in intestines. In the other examined organs, ACE2 protein expression did not change with age. In brain tissue, ACE2 was expressed in astrocytes and endothelial cells.Conclusions . Age-related ACE2 expression differences could be one substrate of the selective clinical vulnerability of the respiratory and gastro-intestinal system to SARS-CoV-2 infection during infancy.